Evidence supporting a mechanistic role of sirtuins in mood and metabolic disorders

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 86, Issue , 2018, Pages 95-101

  Alageel, Asem ^a,b,c   Tomasi, Julia ^d   Tersigni, Claudia ^d   Brietzke, Elisa ^a   Zuckerman, Hannah ^a   Subramaniapillai, Mehala ^a   Lee, Yena ^a,d,e   Iacobucci, Michelle ^a   Rosenblat, Joshua D ^a,c   Mansur, Rodrigo B ^a,c   McIntyre, Roger S ^a,c,d,e  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b AL IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY IMSIU   (Saudi Arabia)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e BRAIN AND COGNITION DISCOVERY FOUNDATION   (Canada)

Author keywords

Bipolar; Depression; Disorder; Metabolic; Mood; Sirtuins

Indexed keywords

ENZYME ACTIVATOR; GLUCOSE; INSULIN; PLACEBO; RESVERATROL; SIRTUIN; SIRTUIN 1; SIRTUIN 2; SIRTUIN 3; SRT 2104; UNCLASSIFIED DRUG;

BLOOD BRAIN BARRIER; CALORIC RESTRICTION; CIRCADIAN RHYTHM; COGNITIVE DEFECT; COMORBIDITY; DEGENERATIVE DISEASE; DEPRESSION; DISEASE ASSOCIATION; DOWN REGULATION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG MECHANISM; DRUG PENETRATION; DRUG REPOSITIONING; EMOTIONAL DISORDER; ENZYME ACTIVITY; ENZYME ANALYSIS; GLUCOSE HOMEOSTASIS; HORMONAL REGULATION; HUMAN; HUNTINGTON CHOREA; HYPERLIPIDEMIA; INSULIN RESISTANCE; LEARNING DISORDER; MEMORY DISORDER; METABOLIC DISORDER; MITOCHONDRIAL RESPIRATION; MOOD DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PSORIASIS; REVIEW; SIGNAL TRANSDUCTION; STRESS; ULCERATIVE COLITIS; ANIMAL; METABOLISM;

ANIMALS; HUMANS; METABOLIC DISEASES; MOOD DISORDERS; SIRTUINS;

EID: 85047458142     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2018.05.017     Document Type: Review

References (70)

1. Abe-Higuchi, N., Uchida, S., Yamagata, H., Higuchi, F., Hobara, T., Hara, K. et al., Hippocampal Sirtuin 1 signaling mediates depression-like behavior. Biol. Psychiatry 80 (2016), 815–826.
2. Ahn, B.-H., Kim, H.-S., Song, S., Lee, I.H., Liu, J., Vassilopoulos, A. et al., A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 14447–14452.
3. Albrecht, U., Molecular mechanisms in mood regulation involving the circadian clock. Front. Neurol., 8, 2017, 30.
4. Amat, R., Planavila, A., Chen, S.L., Iglesias, R., Giralt, M., Villarroya, F., SIRT1 controls the transcription of the peroxisome proliferator-activated receptor-γ co-activator-1α (PGC-1α) gene in skeletal muscle through the PGC-1α autoregulatory loop and interaction with MyoD. J. Biol. Chem. ASBMB 284 (2009), 21872–21880.
5. Andreazza, A.C., Kapczinski, F., Kauer-Sant'Anna, M., Walz, J.C., Bond, D.J., Gonçalves, C.A. et al., 3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. J. Psychiatry Neurosci. 34 (2009), 263–271.
6. Asher, G., Gatfield, D., Stratmann, M., Reinke, H., Dibner, C., Kreppel, F. et al., SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell 134 (2008), 317–328.
7. Baksi, A., Kraydashenko, O., Zalevkaya, A., Stets, R., Elliott, P., Haddad, J., Hoffmann, E., Vlasuk, G.P., Jacobson, E.W., A phase II, randomized, placebo-controlled, double-blind, multi-dose study of SRT2104, a SIRT1 activator, in subjects with type 2 diabetes. Br. J. Clin. Pharmacol. 78 (2014), 69–77.
8. Baur, J.A., Pearson, K.J., Price, N.L., Jamieson, H.A., Lerin, C., Kalra, A. et al., Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444 (2006), 337–342.
9. Brown, N.C., Andreazza, A.C., Young, L.T., An updated meta-analysis of oxidative stress markers in bipolar disorder. Psychiatry Res. 218 (2014), 61–68.
10. Caron, A.Z., He, X., Mottawea, W., Seifert, E.L., Jardine, K., Dewar-Darch, D. et al., The SIRT1 deacetylase protects mice against the symptoms of metabolic syndrome. FASEB J. 28 (2014), 1306–1316.
11. Chang, H.-C., Guarente, L., SIRT1 mediates central circadian control in the SCN by a mechanism that decays with aging. Cell 153 (2013), 1448–1460.
12. Chung, S., Lee, E.J., Yun, S., Choe, H.K., Park, S.-B., Son, H.J. et al., Impact of circadian nuclear receptor REV-ERBα on midbrain dopamine production and mood regulation. Cell 157 (2014), 858–868.
13. Cimen, H., Han, M.-J., Yang, Y., Tong, Q., Koc, H., Koc, E.C., Regulation of succinate dehydrogenase activity by SIRT3 in mammalian mitochondria. Biochemistry 49 (2010), 304–311.
14. Codocedo, J.F., Allard, C., Godoy, J.A., Varela-Nallar, L., Inestrosa, N.C., SIRT1 regulates dendritic development in hippocampal neurons. PLoS One, 7, 2012, e47073.
15. CONVERGE consortium, Sparse whole-genome sequencing identifies two loci for major depressive disorder. Nature 523 (2015), 588–591.
16. Corpas, R., Revilla, S., Ursulet, S., Castro-Freire, M., Kaliman, P., Petegnief, V. et al., SIRT1 overexpression in mouse Hippocampus induces cognitive enhancement through Proteostatic and neurotrophic mechanisms. Mol. Neurobiol. 54 (2017), 5604–5619.
17. Dagon, Y., Avraham, Y., Magen, I., Gertler, A., Ben-Hur, T., Berry, E.M., Nutritional status, cognition, and survival: a new role for leptin and AMP kinase. J. Biol. Chem. 280 (2005), 42142–42148.
18. Finley, L.W.S., Haas, W., Desquiret-Dumas, V., Wallace, D.C., Procaccio, V., Gygi, S.P. et al., Succinate dehydrogenase is a direct target of sirtuin 3 deacetylase activity. PLoS One, 6, 2011, e23295.
19. Gao, J., Wang, W.-Y., Mao, Y.-W., Gräff, J., Guan, J.-S., Pan, L. et al., A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature 466 (2010), 1105–1109.
20. Gerhart-Hines, Z., Rodgers, J.T., Bare, O., Lerin, C., Kim, S.-H., Mostoslavsky, R. et al., Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1α. EMBO J. 26 (2007), 1913–1923.
21. Gomes, P., Outeiro, T.F., Cavadas, C., Emerging role of Sirtuin 2 in the regulation of mammalian metabolism. Trends Pharmacol. Sci. 36 (2015), 756–768.
22. Hallows, W.C., Lee, S., Denu, J.M., Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 10230–10235.
23. Hallows, W.C., Yu, W., Smith, B.C., Devries, M.K., Devires, M.K., Ellinger, J.J. et al., Sirt3 promotes the urea cycle and fatty acid oxidation during dietary restriction. Mol. Cell 41 (2011), 139–149.
24. Hampp, G., Ripperger, J.A., Houben, T., Schmutz, I., Blex, C., Perreau-Lenz, S. et al., Regulation of monoamine oxidase a by circadian-clock components implies clock influence on mood. Curr. Biol. 18 (2008), 678–683.
25. Hatch, J., Andreazza, A., Olowoyeye, O., Rezin, G.T., Moody, A., Goldstein, B.I., Cardiovascular and psychiatric characteristics associated with oxidative stress markers among adolescents with bipolar disorder. J. Psychosom. Res. 79 (2015), 222–227.
26. Hirschey, M.D., Shimazu, T., Goetzman, E., Jing, E., Schwer, B., Lombard, D.B. et al., SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 464 (2010), 121–125.
27. Imai, S., Armstrong, C.M., Kaeberlein, M., Guarente, L., Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403 (2000), 795–800.
28. Jia, Y., Zheng, Z., Wang, Y., Zhou, Q., Cai, W., Jia, W. et al., SIRT1 is a regulator in high glucose-induced inflammatory response in RAW264.7 cells. PLoS One, 10, 2015, e0120849.
29. Jiang, M., Zheng, J., Peng, Q., Hou, Z., Zhang, J., Mori, S., Ellis, J.L., Vlasuk, G.P., Fries, H., Suri, V., Duan, W., Sirtuin 1 activator SRT2104 protects Huntington's disease mice. Ann. Clin. Transl. Neurol. 1:12 (2014), 1047–1052.
30. Jing, E., Emanuelli, B., Hirschey, M.D., Boucher, J., Lee, K.Y., Lombard, D. et al., Sirtuin-3 (Sirt3) regulates skeletal muscle metabolism and insulin signaling via altered mitochondrial oxidation and reactive oxygen species production. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 14608–14613.
31. Julien, C., Tremblay, C., Emond, V., Lebbadi, M., Salem, N. Jr., Bennett, D.A. et al., Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J. Neuropathol. Exp. Neurol. 68 (2009), 48–58.
32. Keller, J., Flores, B., Gomez, R.G., Solvason, H.B., Kenna, H., Williams, G.H. et al., Cortisol circadian rhythm alterations in psychotic major depression. Biol. Psychiatry 60 (2006), 275–281.
33. Kim, H.-D., Hesterman, J., Call, T., Magazu, S., Keeley, E., Armenta, K. et al., SIRT1 mediates depression-like behaviors in the nucleus accumbens. J. Neurosci. 36 (2016), 8441–8452.
34. Kishi, T., Yoshimura, R., Kitajima, T., Okochi, T., Okumura, T., Tsunoka, T. et al., SIRT1 gene is associated with major depressive disorder in the Japanese population. J. Affect. Disord. 126 (2010), 167–173.
35. Kitamura, Y.I., Kitamura, T., Kruse, J.-P., Raum, J.C., Stein, R., Gu, W. et al., FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. Cell Metab. 2 (2005), 153–163.
36. Kudlow, P.A., Cha, D.S., Lam, R.W., McIntyre, R.S., Sleep architecture variation: a mediator of metabolic disturbance in individuals with major depressive disorder. Sleep Med. 14 (2013), 943–949.
37. Li, Y., Xu, S., Giles, A., Nakamura, K., Lee, J.W., Hou, X. et al., Hepatic overexpression of SIRT1 in mice attenuates endoplasmic reticulum stress and insulin resistance in the liver. FASEB J. 25 (2011), 1664–1679.
38. Libri, V., Brown, A.P., Gambarota, G., Haddad, J., Shields, G.S., Dawes, H. et al., A pilot randomized, placebo controlled, double blind phase I trial of the novel SIRT1 activator SRT2104 in elderly volunteers. PLoS One, 7, 2012, e51395.
39. Liu, R., Dang, W., Du, Y., Zhou, Q., Jiao, K., Liu, Z., SIRT2 is involved in the modulation of depressive behaviors. Sci. Rep., 5, 2015, 8415.
40. Liu, T., Yang, W., Pang, S., Yu, S., Yan, B., Functional genetic variants within the SIRT2 gene promoter in type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 137 (2018), 200–207.
41. Luo, X.-J., Zhang, C., Down-regulation of SIRT1 gene expression in major depressive disorder. Am. J. Psychiatry, 173, 2016, 1046.
42. MacQueen, G.M., Memedovich, K.A., Cognitive dysfunction in major depression and bipolar disorder: assessment and treatment options. Psychiatry Clin. Neurosci. 71 (2017), 18–27.
43. McIntyre, R.S., Cha, D.S., Soczynska, J.K., Woldeyohannes, H.O., Gallaugher, L.A., Kudlow, P. et al., Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions. Depress. Anxiety. 30 (2013), 515–527.
44. McIntyre, R.S., Xiao, H.X., Syeda, K., Vinberg, M., Carvalho, A.F., Mansur, R.B. et al., The prevalence, measurement, and treatment of the cognitive dimension/domain in major depressive disorder. CNS Drugs. 29 (2015), 577–589.
45. Michán, S., Li, Y., Chou, M.M.-H., Parrella, E., Ge, H., Long, J.M. et al., SIRT1 is essential for normal cognitive function and synaptic plasticity. J. Neurosci. 30 (2010), 9695–9707.
46. Muñoz-Cobo, I., Belloch, F.B., Díaz-Perdigón, T., Puerta, E., Tordera, R.M., SIRT2 inhibition reverses anhedonia in the VGLUT1 /− depression model. Behav. Brain Res. 335 (2017), 128–131.
47. Nakahata, Y., Kaluzova, M., Grimaldi, B., Sahar, S., Hirayama, J., Chen, D. et al., The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell 134 (2008), 329–340.
48. Nakahata, Y., Sahar, S., Astarita, G., Kaluzova, M., Sassone-Corsi, P., Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1. Science 324 (2009), 654–657.
49. Nivoli, A., Porcelli, S., Albani, D., Forloni, G., Fusco, F., Colom, F. et al., Association between Sirtuin 1 gene rs10997870 polymorphism and suicide behaviors in bipolar disorder. Neuropsychobiology 74 (2016), 1–7.
50. Noh, R.M., Venkatasubramanian, S., Daga, S., Langrish, J., Mills, N.L., Lang, N.N., Hoffmann, E., Waterhouse, B., Newby, D.E., Frier, B.M., Cardiometabolic effects of a novel SIRT1 activator, SRT2104, in people with type 2 diabetes mellitus. Open Heart., 4(2), 2017 Sep 2, e000647.
51. Pallàs, M., Pizarro, J.G., Gutierrez-Cuesta, J., Crespo-Biel, N., Alvira, D., Tajes, M. et al., Modulation of SIRT1 expression in different neurodegenerative models and human pathologies. Neuroscience 154 (2008), 1388–1397.
52. Partonen, T., Treutlein, J., Alpman, A., Frank, J., Johansson, C., Depner, M. et al., Three circadian clock genes Per2, Arntl, and Npas2 contribute to winter depression. Ann. Med. 39 (2007), 229–238.
53. Pfluger, P.T., Herranz, D., Velasco-Miguel, S., Serrano, M., Tschöp, M.H., Sirt1 protects against high-fat diet-induced metabolic damage. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 9793–9798.
54. Porcelli, S., Salfi, R., Politis, A., Atti, A.R., Albani, D., Chierchia, A. et al., Association between Sirtuin 2 gene rs10410544 polymorphism and depression in Alzheimer's disease in two independent European samples. J. Neural Transm. 120 (2013), 1709–1715.
55. Qiu, X., Brown, K., Hirschey, M.D., Verdin, E., Chen, D., Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab. 12 (2010), 662–667.
56. Quintas, A., de Solís, A.J., Díez-Guerra, F.J., Carrascosa, J.M., Bogónez, E., Age-associated decrease of SIRT1 expression in rat hippocampus: prevention by late onset caloric restriction. Exp. Gerontol. 47 (2012), 198–201.
57. Ramadori, G., Lee, C.E., Bookout, A.L., Lee, S., Williams, K.W., Anderson, J. et al., Brain SIRT1: anatomical distribution and regulation by energy availability. J. Neurosci. 28 (2008), 9989–9996.
58. Ramesh, S., Govindarajulu, M., Lynd, T., Briggs, G., Adamek, D., Jones, E. et al., SIRT3 activator Honokiol attenuates β-amyloid by modulating amyloidogenic pathway. PLoS One, 13, 2018, e0190350.
59. Rangarajan, P., Karthikeyan, A., Lu, J., Ling, E.-A., Dheen, S.T., Sirtuin 3 regulates Foxo3a-mediated antioxidant pathway in microglia. Neuroscience 311 (2015), 398–414.
60. Schlicker, C., Gertz, M., Papatheodorou, P., Kachholz, B., Becker, C.F.W., Steegborn, C., Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5. J. Mol. Biol. 382 (2008), 790–801.
61. Schwer, B., Bunkenborg, J., Verdin, R.O., Andersen, J.S., Verdin, E., Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 10224–10229.
62. Shimazu, T., Hirschey, M.D., Hua, L., Dittenhafer-Reed, K.E., Schwer, B., Lombard, D.B. et al., SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production. Cell Metab. 12 (2010), 654–661.
63. Someya, S., Yu, W., Hallows, W.C., Xu, J., Vann, J.M., Leeuwenburgh, C. et al., Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 143 (2010), 802–812.
64. Sun, C., Zhang, F., Ge, X., Yan, T., Chen, X., Shi, X. et al., SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell Metab. 6 (2007), 307–319.
65. Venkatasubramanian, S., Noh, R.M., Daga, S., Langrish, J.P., Mills, N.L., Waterhouse, B.R., Hoffmann, E., Jacobson, E.W., Lang, N.N., Frier, B.M., Newby, D.E., Effects of the small molecule SIRT1 activator, SRT2104 on arterial stiffness in otherwise healthy cigarette smokers and subjects with type 2 diabetes mellitus. Open Heart, 3, 2016, e000402.
66. Wang, R., Zhang, Y., Li, J., Zhang, C., Resveratrol ameliorates spatial learning memory impairment induced by Aβ 1—42 in rats. Neuroscience 344 (2017), 39–47.
67. Wood, J.G., Rogina, B., Lavu, S., Howitz, K., Helfand, S.L., Tatar, M. et al., Corrigendum: Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature, 431, 2004, 107.
68. Yoshizaki, T., Milne, J.C., Imamura, T., Schenk, S., Sonoda, N., Babendure, J.L. et al., SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes. Mol. Cell. Biol. 29 (2009), 1363–1374.
69. Zhang, J., The direct involvement of SirT1 in insulin-induced insulin receptor substrate-2 tyrosine phosphorylation. J. Biol. Chem. 282 (2007), 34356–34364.
70. Zhang, H.-H., Ma, X.-J., Wu, L.-N., Zhao, Y.-Y., Zhang, P.-Y., Zhang, Y.-H. et al., Sirtuin-3 (SIRT3) protects pancreatic β-cells from endoplasmic reticulum (ER) stress-induced apoptosis and dysfunction. Mol. Cell. Biochem. 420 (2016), 95–106.